If you enjoy this content, please share it with a colleague
Invivo Corp.
Invivo is the pioneer in innovative RF coils to increase image quality and improve diagnostic confidence. We are the world leader in MRI monitoring, providing accurate vital signs for improved patient safety.
RELATED CONTENT
Radiologist John Feller, M.D., medical director of Desert Medical Imaging in Indian Wells, Calif., and local urologists have joined forces to test a promising new way to detect and diagnose prostate disease. When a traditional transrectal ultrasound (TRUS) biopsy proves negative for the presence of disease, yet a patient’ s prostate-specific antigen (PSA) levels continue to rise, magnetic resonance imaging’s (MRI) excellent soft-tissue imaging quality may be the answer to a difficult diagnosis.
Over the years, we have seen an evolution in breast imaging. Screening mammography has been able to detect breast cancer in many women who otherwise have no signs or symptoms. Digital mammography and ultrasound are helping to better diagnose breast cancer in its earliest stages. However, no technology is perfect. Mammography sensitivity is only about 50 percent and decreases to 30 percent in women with dense breasts.
Advanced technologies such as magnetic resonance imaging (MRI) are becoming more widely used for both diagnostic and screening purposes.
DynaCAD for prostate and DynaTRIM, both part of Invivo’s Prostate Clinical Solution, give physicians the tools to perform real-time analysis of prostate magnetic resonance imaging (MRI) studies and the support for an MRI-guided prostate biopsy. The device was showcased at RSNA 2010.
Radiology and Urology team up for successful results. Radiologist John Feller, M.D., medical director of Desert Medical Imaging, and local urologists have joined forces to test a promising new way to detect and diagnose prostate disease.
Oncad for DynaCAD is an FDA-cleared, fully automated morphological system for the detection and analysis by a radiologist of suspicious breast lesions. It uses a patented mathematical algorithm to analyze the entire breast and draw a physician’s attention to abnormal morphology during a contrast-enhanced breast MRI.
July 29, 2010 - The Medical Design Excellence Award (MDEA) ceremony, held at New York City’s Jacob K. Javits Convention Center, recognized Invivo as its gold winner for their contributions and advances in the design of medical products in early June.
August 12, 2009 - Invivo Corp. launches DynaTRIM, a first-of-its-kind fully MR compatible interventional device for Trans-Rectal Interventional MR (TRIM) biopsy of the prostate gland.
Invivo’s next-generation MRI patient vital signs monitor, the Precess Patient Management Configuration, is built off of ...
Invivo Corp.’s Luminescence advanced breast MRI coil system is for sites utilizing 8, 16 and 32 channel MRI systems.
The system is an ergonomic modular design with reportedly comfortable patient positioning accessories. The system is available with both interventional coil and an optional 16-channel diagnostic coil.
January 23, 2008 – The Invivo Corp. supplied two of its flagship Precess MRI patient monitors to monitor a pair of ...